Posted inBiotechnology
Posted inMedical Technology
J&J MedTech growth slows again in Q2 as Abiomed weighs on results
Johnson & Johnson’s MedTech business posted operational sales growth of 3.6% in the second quarter, reaching $8.93 billion, as weaker…

















